276 related articles for article (PubMed ID: 12912918)
21. Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.
Scheid MP; Parsons M; Woodgett JR
Mol Cell Biol; 2005 Mar; 25(6):2347-63. PubMed ID: 15743829
[TBL] [Abstract][Full Text] [Related]
22. Threonine phosphorylation of the beta 3 integrin cytoplasmic tail, at a site recognized by PDK1 and Akt/PKB in vitro, regulates Shc binding.
Kirk RI; Sanderson MR; Lerea KM
J Biol Chem; 2000 Oct; 275(40):30901-6. PubMed ID: 10896934
[TBL] [Abstract][Full Text] [Related]
23. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting.
Rena G; Prescott AR; Guo S; Cohen P; Unterman TG
Biochem J; 2001 Mar; 354(Pt 3):605-12. PubMed ID: 11237865
[TBL] [Abstract][Full Text] [Related]
24. Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX.
Woods YL; Rena G
Biochem Soc Trans; 2002 Aug; 30(4):391-7. PubMed ID: 12196101
[TBL] [Abstract][Full Text] [Related]
25. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.
Scheid MP; Marignani PA; Woodgett JR
Mol Cell Biol; 2002 Sep; 22(17):6247-60. PubMed ID: 12167717
[TBL] [Abstract][Full Text] [Related]
26. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
Biondi RM; Nebreda AR
Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
[TBL] [Abstract][Full Text] [Related]
27. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast.
Casamayor A; Torrance PD; Kobayashi T; Thorner J; Alessi DR
Curr Biol; 1999 Feb; 9(4):186-97. PubMed ID: 10074427
[TBL] [Abstract][Full Text] [Related]
28. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.
Park J; Leong ML; Buse P; Maiyar AC; Firestone GL; Hemmings BA
EMBO J; 1999 Jun; 18(11):3024-33. PubMed ID: 10357815
[TBL] [Abstract][Full Text] [Related]
29. Yeast 3-phosphoinositide-dependent protein kinase-1 (PDK1) orthologs Pkh1-3 differentially regulate phosphorylation of protein kinase A (PKA) and the protein kinase B (PKB)/S6K ortholog Sch9.
Voordeckers K; Kimpe M; Haesendonckx S; Louwet W; Versele M; Thevelein JM
J Biol Chem; 2011 Jun; 286(25):22017-27. PubMed ID: 21531713
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
Guo S; Rena G; Cichy S; He X; Cohen P; Unterman T
J Biol Chem; 1999 Jun; 274(24):17184-92. PubMed ID: 10358076
[TBL] [Abstract][Full Text] [Related]
31. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.
Frödin M; Jensen CJ; Merienne K; Gammeltoft S
EMBO J; 2000 Jun; 19(12):2924-34. PubMed ID: 10856237
[TBL] [Abstract][Full Text] [Related]
32. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
[TBL] [Abstract][Full Text] [Related]
33. The choreography of protein kinase PDK1 and its diverse substrate dance partners.
Leroux AE; Biondi RM
Biochem J; 2023 Oct; 480(19):1503-1532. PubMed ID: 37792325
[TBL] [Abstract][Full Text] [Related]
34. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation.
Haga S; Ozaki M; Inoue H; Okamoto Y; Ogawa W; Takeda K; Akira S; Todo S
Hepatology; 2009 Jan; 49(1):204-14. PubMed ID: 19065678
[TBL] [Abstract][Full Text] [Related]
35. Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation.
Filippa N; Sable CL; Hemmings BA; Van Obberghen E
Mol Cell Biol; 2000 Aug; 20(15):5712-21. PubMed ID: 10891507
[TBL] [Abstract][Full Text] [Related]
36. PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.
Harris TK
IUBMB Life; 2003 Mar; 55(3):117-26. PubMed ID: 12822887
[TBL] [Abstract][Full Text] [Related]
37. AGC kinases, mechanisms of regulation and innovative drug development.
Leroux AE; Schulze JO; Biondi RM
Semin Cancer Biol; 2018 Feb; 48():1-17. PubMed ID: 28591657
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
39. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane.
Maira SM; Galetic I; Brazil DP; Kaech S; Ingley E; Thelen M; Hemmings BA
Science; 2001 Oct; 294(5541):374-80. PubMed ID: 11598301
[TBL] [Abstract][Full Text] [Related]
40. The PI3K-PDK1 connection: more than just a road to PKB.
Vanhaesebroeck B; Alessi DR
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):561-76. PubMed ID: 10698680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
